Fluorescence
tumor imaging using exogenous fluorescent
tumor-targeting agents has potential to improve early
tumor detection. The fluorescent
contrast agent indocyanine green (ICG) is used in medical diagnostics. The aim of the present study is to investigate the
tumor imaging capability and the imaging mechanism of i.v. administered ICG in a mouse model of
colitis-associated colon cancer. To do this, an
azoxymethane/
dextran sodium sulfate-induced
colon cancer mouse model was used. Ex vivo imaging experiments were carried out 1 hour after i.v. injection of ICG. The ICG fluorescence was observed in the colon
tumor tissues, with sufficient
tumor to normal tissue ratio, correlating with
tumor malignancy. In the
tumor tissues, ICG fluorescence was localized in the vascular interstitial tissue. Immunofluorescence microscopy revealed that
tumor cells formed tight junctions normally, suggesting an inability of
tumor cellular uptake of ICG. In contrast,
tumor tissues increased the CD31-immunoreactive endothelial cell area, and accumulated stromal cells immunoreactive for COX-2 and
tumor cell population immunoreactive for
inducible nitric oxide synthase. In vivo vascular permeability assay revealed that
prostaglandin E2 promoted the endothelial cell permeability of ICG. In conclusion, our data indicated that fluorescence contrast-enhanced imaging following i.v. administered ICG can be applied to the detection of colon
tumors in a mouse
colitis-associated colon cancer model. The
tumor tissue preference of ICG in the present model can be attributed to the enhanced vascular leakage of ICG involving inflammatory mediators, such as COX-2 and
inducible nitric oxide synthase, in conjunction with increased
tumor vascularity.